Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 842 of 1,261
  1. US 8592454

    Nitrogen-containing heterocyclic compound and use of same

    Takeda Pharmaceutical Company Limited · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  2. US 8592453

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  3. US 8586626

    Metabolites of wortmannin analogs and methods of using the same

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  4. US 8586526

    DNA-binding proteins and uses thereof

    Sangamo Biosciences, Inc. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  5. US 8586363

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  6. US 8586317

    Methods of diagnosing hypophosphatemic disorders

    Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  7. US 8586308

    Genetic markers of mental illness

    SureGene LLC · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  8. US 8586291

    Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571

    The Regents of the University of California · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  9. US 8586046

    Methods and compositions for mycoplasma pneumoniae exotoxins

    The Board of Regents of the University of Texas System · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  10. US 8586006

    Organ-specific proteins and methods of their use

    INTEGRATED DIAGNOSTICS, INC. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  11. US 8586044

    Treatment of chronic pelvic pain syndrome

    Northwestern University · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  12. US 8586055

    DNA immunization protocols

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  13. US 8586553

    Therapies for cancer using RLIP76

    The Board of Regents of the University of Texas System · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  14. US 8586610

    Methods for the administration of iloperidone

    VANDA PHARMACEUTICALS INC. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  15. US 8586571

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  16. US 8586589

    Piperidine and piperazine phenyl sulfonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  17. US 8586615

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  18. US 8586681

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  19. US 8586711

    Polymer-factor IX moiety conjugates

    Nektar Therapeutics · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  20. US 8586762

    Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  21. US 8586536

    Neprilysin inhibitors

    Theravance, Inc. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  22. US 8586713

    Readily isolated bispecific antibodies with native immunoglobulin format

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  23. WO 2013169458

    COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES DE TRAITEMENT, DE CONTRÔLE, D'AMÉLIORATION, OU D'INVERSION DES TROUBLES DE LA KÉRATOCONJONCTIVITE SÈCHE

    BAUSCH & LOMB [US] · Granted Nov 14, 2013 · Expires Nov 9, 2033

    granted
  24. EP 2662386

    Antikörper, die an PLAC1 binden und die Wechselwirkung zwischen PLAC1 und FGF7 inhibieren

    BIONTECH AG [DE] · Granted Nov 13, 2013 · Expires Nov 8, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.